At #BSH2024 , Dr Deepti Radia (@G_ICEMD) presented the updated analyses from the PATHFINDER trial investigating avapritinib therapy in patients with advanced systemic #Mastocytosis .
Watch the interview here:
👉 ow.ly/78FG50RvyjT
#HemOnc #MPNsm #CTSM #TrialUpdate BSH - Haematology
The Phase II ANIMATE trial is investigating PET response-adapted treatment using nivolumab in pts with R/R classical #HodgkinLymphoma .
Graham Collins (@OUHospitals) presents the first results:
👉 ow.ly/lKnR50Rvz3V
#BSH2024 BSH - Haematology #HemOnc #CTSM #LYMsm #TrialUpdate
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages [Apr 27, 2024] McKelvey et al. Diagnostics MDPI mdpi.com/2075-4418/14/9… #LiquidBiopsy #ctsm
Social Media in #ClinicalTrials Mike Thompson, MD, PhD, FASCO #ASCO14 Educational Book ascopubs.org/doi/10.14694/E… #ctsm
Use of a Clinical Trial Screening Tool to Enhance Patient Accrual [Feb 19, 2021] St. Germain & McCaskill-Stevens - ACS Journal Cancer ow.ly/VvBl50DGOgu #ClinicalTrials #ctsm #NCORP